AXON - Educational Analysis * US Equities
Educational Analysis * US Equities

AXON

Earnings behavior, post-earnings drift, and the gap between consensus and the market's real expectation - the educational primer before you look at the institutional verdict.

Educational content only - not investment advice. Nothing on this page is a recommendation to buy or sell any security. Historical patterns do not predict future outcomes. Consult a licensed financial advisor before making any trading decision.
Published byGamma QC editorial
TickerAXON
CategoryEducational primer
Last reviewedNovember 17, 2026
You're viewing an older edition of this page.Read the latest edition →

Business Profile & Competitive Position

Axon Enterprise, Inc. operates in the Industrials sector, specifically the Aerospace & Defense industry, although its products sit at the intersection of defense technology and public-safety software. The company sells an integrated platform that connects TASER energy devices, body cameras, in-car cameras, sensors, drones, and counter-drone systems with cloud-based evidence and records management, real-time operations software, AI-enhanced productivity tools, and immersive training. Headquartered in Scottsdale, Arizona, Axon performs manufacturing, final assembly, and final testing at its Arizona facilities, which carry ISO 9001 and ISO 9001:2015 certifications.

Axon’s reported numbers tell a mixed story about competitive strength. The company carries a 7.6% net margin and a 7.3% return on equity. Those figures are not especially wide, which suggests that despite its well-known brand and recurring software revenue, the business is still absorbing hardware costs, R&D investment, and international expansion spending. The fact that annual recurring revenue reached $1.3 billion as of December 31, 2025 is a clear positive, because recurring license, integration, warranty, and storage revenue can provide steadier cash flow than one-time hardware sales. Additionally, no single customer represented more than 10% of total net sales in 2023, 2024, or 2025, indicating a diversified customer base and limited concentration risk. Still, the modest margin and ROE imply that Axon’s economic moat is likely built on switching costs and platform integration rather than on unusually high pricing power.

Financial Posture

At a $25.0 billion market capitalization, Axon trades at a trailing P/E of 95.8. That multiple is very high relative to the company’s 7.6% net margin and 7.3% ROE. In plain terms, the current valuation appears to price in years of rapid growth and a successful transition toward higher-margin software and services, rather than reflecting today’s bottom-line profitability.

The balance between growth narrative and current profitability is important. A beta of 1.47 means the stock has historically been roughly 47% more volatile than the broader market, so moves tend to be magnified in both directions. With the current price at $306.44, the 50-day EMA sits far above at $412.54, and the RSI is 28.4. Those technical readings point to a sharp recent pullback and technically oversold conditions, but they do not by themselves indicate whether the stock is cheap or expensive on a fundamental basis.

Strategic Priorities & Outlook

According to Axon’s most recent 10-K filing, the company is realigning itself into two reportable segments: Software and Services, and Connected Devices. The stated goal is to increase transparency between the higher-margin software/services business and the hardware business as each segment grows.

Management also emphasizes international expansion across Europe, Asia, and the Americas, supported by investments in sales personnel and strategic headcount additions. The filing repeats a goal of building “highly recurring, highly profitable businesses,” with ongoing R&D and purposeful product innovation as the primary growth drivers. The $1.3 billion in annual recurring revenue as of December 31, 2025 is the concrete data point supporting that transition. Because no customer exceeded 10% of net sales in the last three years, the business is not overly dependent on a single contract, which gives management more flexibility to pursue new geographies and product lines.

Macro & Geopolitical Exposure

As an Aerospace & Defense company, Axon is exposed to government procurement and budget cycles at federal, state, and local levels. Sales of TASER devices, cameras, drones, and counter-drone systems can be influenced by law-enforcement budgets, defense appropriations, and public-policy debates around policing and surveillance technology.

Regulatory risk is also relevant. Axon’s AI-enhanced software, evidence-management systems, and drone/counter-drone products sit in heavily scrutinized areas, including data privacy, facial recognition, autonomous systems, and export-control rules. International expansion adds currency-translation risk and potential tariff or trade-policy headwinds, especially if electronics supply chains or finished goods cross borders. Supply-chain disruptions for semiconductors, sensors, and other hardware components could also affect the Connected Devices segment.

Recent Developments

Several recent headlines have brought attention to Axon. On November 15, 2026, defenseworld.net reported that Aberdeen Group plc had boosted its AXON stock holdings. Two days earlier, on November 13, 2026, prnewswire.com published a securities investigation notice from Levi & Korsinsky. That same day, zacks.com ran an article asking whether investors should buy, hold, or sell AXON stock following the Q3 earnings release. On November 12, 2026, zacks.com also published a piece noting that Axon was attracting investor attention. These headlines reflect both institutional interest and post-earnings uncertainty around the stock.

Earnings Behavior & Post-Earnings Drift

Axon has beaten earnings expectations in 6 of the last 8 quarters, a 75% beat rate, with an average earnings surprise of 14.3%. Across those eight reports, the average 5-day price move after earnings has been 1.8% to the upside, classified as an “up” drift.

The four most recent quarters show how volatile the post-earnings reaction can be. On February 24, 2026, Axon reported EPS of $2.15 against an estimate of $1.60, a 34.4% positive surprise; the stock rose 17.55% the next day and 30.86% over the following five sessions. On May 6, 2026, EPS of $1.61 barely beat the $1.60 estimate (0.6% surprise), yet the stock still jumped 10.63% the next day before sliding 2.34% over five days. On August 5, 2026, a modest 2.2% beat with EPS of $1.88 versus $1.84 was met with a 14.28% single-day drop and a 1.59% five-day decline. Most recently, on November 5, 2026, Axon missed badly: actual EPS was $1.72 versus the market’s real expectation of $1.89, a 9% negative surprise, sending the stock down 18.18% the next day and 19.72% over the following five days.

The next scheduled report is February 23, 2027, after the close, with a current consensus EPS estimate of $1.98. Given the gap between the current price ($306.44) and the 50-day EMA ($412.54), and an RSI of 28.4, the stock has already repriced sharply lower following the November miss. Traders watching this name should keep in mind that Axon combines a high-multiple valuation with above-average volatility, meaning earnings days can produce outsized swings even when headline beats or misses look small.

For a deeper dive into institutional sentiment, price-implied expectations, and how sell-side models are evolving after the November miss, readers can review the full institutional verdict on AXON.

Frequently Asked Questions

What does Axon actually sell?

Axon provides an integrated public-safety and security platform that combines TASER energy devices, body and in-car cameras, sensors, drones, and counter-drone systems with cloud-based evidence and records management, real-time operations software, AI-enhanced productivity tools, and immersive training.

How has Axon performed around earnings?

Over the last eight quarters, Axon has beaten estimates 75% of the time, with an average earnings surprise of 14.3% and an average 5-day post-earnings drift of 1.8% to the upside. However, the November 5, 2026 miss produced an 18.18% one-day drop, showing that the stock’s reactions can be extreme.

What macro risks matter for Axon?

Because Axon is classified in Aerospace & Defense, it faces exposure to government budgets, law-enforcement procurement cycles, regulation around surveillance, AI, and drones, export controls, currency translation, and supply-chain risk for hardware components.

Real Data - Gamma QC Earnings IntelligenceAs of Nov 17, 2026
Axon Enterprise, Inc. · Industrials / Aerospace & Defense
$25.0BMarket cap
95.8P/E
7.6%Net margin
7.3%ROE
75%Beat rate, last 8Q
14.3%Avg EPS surprise
1.8%Avg 5-day move after earnings
2027-02-23Next earnings
ReportedActualEstimateSurprise1D Move5D Move
2026-11-05$1.72$1.89-9%-18.18%-19.72%
2026-08-05$1.88$1.84+2.2%-14.28%-1.59%
2026-05-06$1.61$1.6+0.6%+10.63%-2.34%
2026-02-24$2.15$1.6+34.4%+17.55%+30.86%
2025-11-04$1.17$1.52-23%--
2025-08-04$2.12$1.45+46.2%--

Previous AXON editions

Beyond the primer

Get the institutional verdict on AXON

Seven-seat 21-ERT council. Pre-print forecast signed before the earnings release. Post-print grade, published in public. Every verdict sealed with a cryptographic receipt.

Read the AXON verdict at Gamma QC
$49 Pro / $249 RIA * gammaqc.com

Verify authenticity

Every Gamma QC verdict is signed with a cryptographic receipt at issuance. Independently verify any published verdict at attest.gammaqc.com. This educational primer is content-only and not itself signed; the institutional verdict at the link above is.